Medical Science News

RSS

New mathematical models can predict prostate cancer aggressiveness

Alexander R. A. Anderson, Ph.D., co-director of Integrative Mathematical Oncology (IMO) at Moffitt Cancer Center, and his colleagues, Simon Hayward, Ph.D., at Vanderbilt University and Gustavo Ayala, M.D., at Baylor College of Medicine, have received a five-year, $3 million grant from the National Institutes of Health to create new mathematical models to predict prostate cancer aggressiveness.

22 Oct 2011

Biomarker can help identify GVHD in cancer patients after hematopoietic stem cell transplant

A University of Michigan Health System-led team of researchers has found a biomarker they believe can help rapidly identify one of the most serious complications in patients with leukemia, lymphoma and other blood disorders who have received a transplant of new, blood-forming cells.

22 Oct 2011

Clues into how gene defects may cause ARPKD in babies

Babies born with autosomal recessive polycystic kidney disease (ARPKD) often develop kidney failure because they have very large kidneys filled with tiny cysts. Even with excellent medical care, about 30% die shortly after birth. New research now provides clues into how gene defects may cause this condition, which occurs in 1 out of 20,000 newborns.

22 Oct 2011

SCP acts as an important inhibitor of cancer cell migration and growth

A revolutionary discovery regarding motile cancer cells made by research scientists at VTT Technical Research Centre of Finland and the University of Turku is challenging previous conceptions.

22 Oct 2011

MRI helps researchers to study molecules directly in organs and tissue

Researchers at Lund University can now study molecules which are normally only found in very small concentrations, directly in organs and tissue. After several years of work, researchers in Lund have managed to construct an instrument that 'hyperpolarises' the molecules and thus makes it possible to track them using MRI.

22 Oct 2011

Researchers identify cancer cell cycle-regulated mechanism

Researchers from the NYU Cancer Institute, an NCI-designated cancer center at NYU Langone Medical Center, have identified a cell cycle-regulated mechanism behind the transformation of normal cells into cancerous cells.

22 Oct 2011

Two proteins bind together to ignite and sustain malignant brain tumors

Two previously unassociated proteins known to be overly active in a variety of cancers bind together to ignite and sustain malignant brain tumors, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports this week in the journal Cancer Cell.

22 Oct 2011

New neuroconomics study reveals how you make decisions

New research reveals how we make decisions. Birds choosing between berry bushes and investors trading stocks are faced with the same fundamental challenge - making optimal choices in an environment featuring varying costs and benefits.

22 Oct 2011

Blood pressure-lowering medication appears to kick start brain recovery after stroke

A commonly prescribed blood pressure-lowering medication appears to kick start recovery in the unaffected brain hemisphere after a stroke by boosting blood vessel growth, a new University of Georgia study has found.

22 Oct 2011

Participants invited for DHA-rich fish oil supplement study on mental performance

A particular fish oil (omega-3) supplement has been shown to improve blood flow to the brain during mental activity and to impact on certain aspects of mental performance in young adults, according to research from Northumbria University.

21 Oct 2011

Geron announces data from ongoing GRNOPC1 Phase 1 trial on spinal cord injury

Geron Corporation today announced two presentations on the company's ongoing Phase 1 clinical trial of its human embryonic stem cell-based therapy, GRNOPC1, in patients with spinal cord injury.

21 Oct 2011

NIH awards DNASU $6.5M grant to expand Protein Structure Initiative-Materials Repository

Arizona State University's Biodesign Institute- is home to a rich trove of biological material. Known as DNASU, this growing storehouse-a sort of genetic Library of Congress-holds over 147,000 plasmids, (circular DNA samples that can be used to produce individual proteins), as well as full genome collections from numerous organisms and proteins associated with many leading human diseases.

21 Oct 2011

Wake up refreshed with a brain-monitoring alarm clock

We all know the feeling, the short, sharp shock of waking to the sound of an alarm clock. Whether the traditional clattering metal bells, the incessant beeping of digital or the dulcet tones of today's radio news reader. Even the chance to slap the snooze button to grab a few extra moments between the sheets does not leave everyone feeling refreshed when they finally crawl out of bed. Now, researchers in India think they have the answer.

21 Oct 2011

Imaging study shows slower brain growth in children with autism

Researchers at UCLA have found a possible explanation for why autistic children act and think differently than their peers. For the first time, they've shown that the connections between brain regions that are important for language and social skills grow much more slowly in boys with autism than in non-autistic children.

21 Oct 2011

Bristol scientist to unlock secrets of miniscule algae cells that produce silica

A scientist at the University of Bristol has been awarded £1.3 million to unlock the secrets of miniscule algae cells that have the remarkable ability to produce silica - the fundamental constituent of glass. It is hoped the findings from the research could lead to the next generation of medical imaging tools.

21 Oct 2011

Preclinical data from Teva's COPAXONE study on multiple sclerosis

Teva Pharmaceutical Industries Ltd. today announced preclinical data demonstrating reparative and neuroprotective effects of treatment with COPAXONE (glatiramer acetate injection) in experimental autoimmune encephalomyelitis (EAE) models.

21 Oct 2011

Inhibition of miR-33a/b suppresses triglyceride levels, increases HDL-C cholesterol

Researchers at NYU Langone Medical Center today announce findings published in the October 20 issue of Nature that show for the first time the inhibition of both microRNA-33a and microRNA-33b (miR-33a/b) with chemically modified anti-miR oligonucleotides markedly suppress triglyceride levels and cause a sustained increase in high density lipoprotein cholesterol (HDL-C) "good" cholesterol.

21 Oct 2011